SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Unaudited First Half of 2017 Financial
[Sinovac Reports Unaudited First Half of 2017 Financial Results BEIJING, China, December 1, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, announced today that it reported its unaudited financial results]